References

Asboe-Hansen G (1985) Epidemiology of progressive systemic sclerosis in Denmark. In: Black CM, Myers AR (eds) Systemic Sclerosis (Scleroderma). Gower, New York, p 78

Ball C, Sackett D, Phillips B, Haynes B, Straus S (1999) Levels of evidence and grades of recommendations

Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, Salagnac V, Lok C, Roujeau JC (1996) Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 132: 272-276

Bernard P, Vaillant J, Labeille B, Bedane C, Arbeille B, Denoeux JP et al. (1995) Incidence and distribution of subepidermal bullous skin diseases in three french regions. Arch Dermatol 131: 48-52

Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4th edn Springer, Berlin Heidelberg New York

Burns CG (1994) The epidemiology of systemic sclerosis: a population-based case-control study, PhD dissertation (Epidemiological Sciences), University of Michigan

Connell EB (1998) The exploitation of autoimmune disease: breast implant litigation and its dire implications for women's health. J Womens Health 7: 329-338 Cooper GS, Dooley MA, Treadwell EL, St. Clair WE, Gilkeson GS (2001) Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 28(12): 2653-2656

Cooper GS, Dooley MA, Treadwell EL, St.Clair EW, Gilkeson GS (2002a) Hormonal and Reproductive Risk Factors for Development of Systemic Lupus Erythematosus. Arthritis Rheum 46: 1830-1839

Cooper GS, Dooley MA, Treadwell EL, St.Clair EW, Gilkeson GS (2002b) Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history. J Clin Epidemiol 55: 982-989 Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2: 119-125

Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler MJ (1998) A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol 25: 254-260

Englert HJ, Brooks P (1994) Scleroderma and augmentation mammoplasty - a causal relationship? Austr NZ J Med 24: 74-80 Englert H, Small-McMahon J, Chambers P, O'Connor H, Davis K, Manolios N, White R, Dracos

G, Brooks P (1999a) Familial risk estimation in systemic sclerosis. AustNZJMed29: 36-41 Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P (1999b) Systemic

Sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 29: 42-50 Fessel WJ (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptomes; the high prevalence in black women. Arch Intern Medicin 134:1027-1035

Fujikawa S, Okuni M (1997) A nationwide surveillance study of rheumatic diseases among

Japanese children. Acta Paediatr Jpn 39: 242-244 Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330: 1697-1702

Gallego H, Crutchfield CE, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63: 231-234 Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson (1994) Systemic sclerosis in Iceland:

A nationwide epidemiological study. Ann Rheum Dis 53: 502-505 Giltay EJ, Moens HJB, Riley AH, Tan RG (1994) Silicone breast protheses and rheumatic symptoms: a retrospective follow-up study. Ann Rheum Dis 53: 194-196 Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH (1995) Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 48: 571-582

Grattan CEH (1985) Evidence of an association between bullous pemphigoid and psoriasis.

Br J Dermatology 113: 281-283 Guillaume JC, Roujeau JC, Touraine R (1984) Systemic lupus after breast prosthesis. Ann

Dermatol Venerol 111: 703-704 Gutierrez FJ, Espinoza LR (1990) Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 89: 390-392 Haga HJ, Haaland P, Haga T (1992) Silicone breast implants and collagen diseases. Tidsskr

Nor Laegeforen 112: 763-764 Hammer M, Krippner H (1991) Three cases of chronic polyarthritis after silicon implantation

(breast augmentation): causal realtionship? Immun Infekt 19: 62-63 Hennekens CH, Lee IM, Cook NR, Hebert PR, Karlson EW, LaMotte F, Manson JAE, Buring JE (1996) Self-reported breast implants and connective-tissue diseases in female health professionals - A retrospective cohort study. JAMA 275: 616-621 Hochberg MC (1985) The incidence of lupus erythematosus in Baltimore, Maryland 19701977. Arthritis Rheum 28: 80-86 Hochberg MC, Perlmutter DL, Medsger TA Jr, Nguyen K, Steen V, Weisman MH, White B, Wigley FM (1996) Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39: 1125-1131

Hopkinson ND, Doherty M, Powell RJ (1993) The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 32: 110-115 Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/ prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53: 675-680 Hopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ (2000) Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 59: 116-119 Jacobson DL, Gange SJ, Rose NR, Graham NMH (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immuno-path 84: 223-243

Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302: 766-768 Johnson AE, Cavalcanti FS, Gordon C, Nived O, Palmer RG, Sturfelt G, Viner NJ, Bacon PA (1994) Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus 3: 501-506 Jung M, Kippes W, Messer G, Zillikens D, Rzany B (1999) Increased risk of bullous pemphigoid in male and very old patients. A population-based study on incidence. J Am Acad Dermatol 41: 266-268

Kaipiainen-Seppänen O, Aho K (1996) Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J Intern Med Kaipiainen-Seppänen O, Savolainen A (1996) Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 14: 441-444 Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN, Stern SH, Straaton KV, Wacholtz MC, Grosflam JM et al. (1995) The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 38: 267-273 Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fessel AH, Roberts WN, Stern SH, Straatom KV, Wachotz MC, Kavanaugh AF, Grosflam JM, Liang MH (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40: 47-56 Kind P, Goerz G (1987) Klinik und Differentialdiagnose des kutanen Lupus erythematodes,

Z Hautkr 62: 1337-1347 Kumagai Y, Shiokawa Y, Medsger TJ, Rodnan GP (1984) Clinical spectrum of CTD after cosmetic surgery. Observations on eighteen patients and review of the Japanese literature. Arthritis Rheum 27: 1-12 Lawrence JS, Martins CL, Drake GL (1987) A family survey of lupus erythematosus. I.

Heritability. J Rheumatol 14: 913-921 Lilienfeld DE, Stolley PD (1994) Foundations of Epidemiology 3rd edn Oxford University Press, New York Oxford

MaricqHR, WeinrichMC, Keil JE, Smith EA, Harper FE, Nussbaum AI, LeRoy EC, McGregor AR, Diat F, Rosal EJ (1989) Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32: 998-1002 Marik PE, Kark AL, Zambakides A (1990) Scleroderma after silicone augmentation mammo-

plasty. A report of 2 cases. S Afr Med J 77: 212-213 Masouye I, Schmied E, Didierjean I (1998) Bullous pemphigoid and multiple sclerosis: more than a coincidence? J Am Acad Dermatol 21: 63-68 Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D (2003) Prevalence, Incidence, Survival, and Disease Characteristics of Systemic Sclerosis in a Large US Population. Arthritis Rheum 48: 2246-2255 Mayes MD, Laing TJ, Gillespie BW et al. (1996) Prevalence, incidence and survival rates of systemic sclerosis in the Detroit metropolitan area. Arthritis Rheum 39: 5150 Meier CR, Sturkenboom MCJM, Cohen AS, Jick H (1998) Postmenopausal Estrogen Replacement Therapy and the Risk of Developin Systemic Lupus Erythematosus or Discoid Lupus. J Rheumatol 25: 1515-1519 Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minne-sota,1950 through 1979. Mayo Clin Proc 60: 105-113

Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Nishijo K, Higashibara M, Shiragami H, Ohno F (1964) Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 2122: 9 Molad Y (1987) Clinical manifestations and labaratory data of subacute cutaneous lupus erythematosus. Israel J Med Sci 23: 278-280 Mooney E, Wade TR (1989) Subacute cutaneous lupus erythematosus in Iceland. Int J Dermatol 28: 104-106

Nagata C, Fujita S, Iwata H, Kurosawa Y, Kobayashi K, Kobayashi M, Motegi K, Omura T, Yamamoto M, Nose T, Nakamura K-I, Hashimoto T, Nakamura Y, Yanagawa H (1995) Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 34:333-337

Nyrén O, Yin L, Josefsson S, McLaughlin JK, Blot WJ, Engqvist M, Hakelius L, Boice Jr JD, Adami H-O (1998) Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 316: 417-422

Park AJ, Black RJ, Sarhadi NS, Chetty U, Watson ACH (1997). Silicone gel-filled breast implants and connective tissue disease. Plast Reconstr Surg 101: 261-268 Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS, Hoppin JA, Savitz DA (2002) Occupational Exposure to Crystalline Silica and Risk of Systemic Lupus Erythematosus. Arthritis Rheum 46: 1840-1850

Pelkonen P, Jalanko H, Lantto RK, Makela AC, Pietikainen MA, Savolainen HA, Verronen PM (1994) Incidence of systemic connective tissue diseases in children: A nationwide prospective study in Finland. J Rheumatol 21: 2143-6 Perkins LL, Clark BD, Klein PJ, Cook RR (1995) A meta-analysis of breast implants and connective tissue disease. Ann Plast Surg 35: 561-570 Peterson LS, Nelson AM, Su WPD, Mason T, O'Fallon M, Gabriel SE (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheum 24: 73-80 Pisa FE, Bovenzi M, Romeo L, Tonello A, Biasi D, Bambara LM, Betta A, Barbone F (2002) Reproductive factors and the risk of sclerodermia. An Italian case-control study. Arthritis Rheum 46: 451-456

Rzany B, Coresh J, Whelton PK, Petri M (1999) Risk factors for hypercreatinemia in patients with systemic lupus erythematosus (SLE). Lupus 8: 532-540 Rzany B, Danckwardt C, Jung M, Schuhmann M, Messer G, Bayerl C (2000) Erhöhtes Risiko von Malignomerkrankungen mit bullösem Pemphigoid. Akt Dermatol 26: 53-59 Sánchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA (1995a) Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus. Ann Intern Med 122: 430-433

Sánchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH (1995b) Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 332: 1666-1670

Schlesselmann JJ (1982) Case-Control Studies: Design, Conduct, Analysis. New York Oxford, Oxford University Press Schusterman MA, Kroll SS, Reece GP, Miller MJ, Ainslie N, Halabi S, Balch CM (1993) Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 31: 1-6 Shopland DR, Hartman AM, Gibson JT et al. (1996) Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J Natl Cancer Inst 88: 1748-1758

Siegel M, Lee SL (1973) The epidemiology of systemic lupus erythematosus. Arthritis Rheum 3: 1-54

Silman A, Jannini S, Symmons D, Bacon P (1988) An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27: 286-290 Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus -A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115: 14091415

Spiera H (1988) Scleroderma after silicone augmentation mammoplasty. JAMA 260: 236-238

Strom BL, Reichenberger MM, West S, Snyder ES, Freundlich B, Stolley PD (1994) Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 140: 632-42 Stone SP, Schroeter AL (1975) Bullous Pemphigoid and Malignant Neoplasms. Arch Dermatol 111: 991-994

Tamaki T, Mori S, Takehara K (1991) Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283: 366-370 Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950 - 1992. Arthritis Rheum 42: 46-50

Valter I, Saretok S, Maricq HR (1997) Prevalence of Scleroderma Spectrum Disorders in the

General Population of Estonia. Scand J Rheumatol 26: 419-425 Van Numen SA, Gatenby PA, Basten A (1982) Postmammoplasty connective tissue disease.

Arthritis Rheum 25: 694-697 Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case-control study. Br J Dermatol 123: 439-445 Venning VA, Whitehead PH, Leigh IM, Allen J, Wojnarowska F (1991) The clinical expression of bullous pemphigoid is not determined by the specifity of the target antigen. Br J Dermatol 125: 561-565

Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350: 1097-1099

Weinstein C (1987) Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust NZ J Med 17: 501-506 Weisman MH, Vecchione TR, Albert D, Moore LT, Mueller MR (1988) CTD following breast augmentation: a preliminary report. Ann Plast Surg 82: 626-630 Wells KE, Cruse CW, Baker JL, Daniels SM, Stern RA, Newman C, Seleznick MJ, Vasey FB, Brozena S, Albers SE, Frenske N (1994) The health status of women following cosmetic surgery. Plast Reconstr Surg 93: 907-912 Wigley FM, Miller R, Hochberg MC, Steen V (1992) Augmentation mammoplasty in patients with systemic sclerosis: data from the Baltimore Scleroderma Research Center and Pittsburgh Scleroderma Data Bank. Arthritis Rheum 35: 65 www.cochrane.org (2000)

Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Bröcker EB (1995) Incidence on autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131: 957-958

Allergic To Everything

Allergic To Everything

The human body And Todays chemical infested world. Here is a news flash You are not allergic to pollen, pet dander, or whatever it is that makes your body revolt Rather, your body just can not handle that one thing, what ever it is, anymore, due to the massive barrage of toxic chemicals you and everyone else are ingesting every single day.

Get My Free Audio and Ebook


Post a comment